BE876296A - Compositions pharmaceutiques contenant des prostaglandines - Google Patents

Compositions pharmaceutiques contenant des prostaglandines

Info

Publication number
BE876296A
BE876296A BE0/195196A BE195196A BE876296A BE 876296 A BE876296 A BE 876296A BE 0/195196 A BE0/195196 A BE 0/195196A BE 195196 A BE195196 A BE 195196A BE 876296 A BE876296 A BE 876296A
Authority
BE
Belgium
Prior art keywords
pharmaceutical compositions
compositions containing
containing prostaglandins
prostaglandins
formulations
Prior art date
Application number
BE0/195196A
Other languages
English (en)
French (fr)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of BE876296A publication Critical patent/BE876296A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BE0/195196A 1978-05-17 1979-05-16 Compositions pharmaceutiques contenant des prostaglandines BE876296A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2017578 1978-05-17

Publications (1)

Publication Number Publication Date
BE876296A true BE876296A (fr) 1979-11-16

Family

ID=10141640

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/195196A BE876296A (fr) 1978-05-17 1979-05-16 Compositions pharmaceutiques contenant des prostaglandines

Country Status (28)

Country Link
US (1) US4335139A (xx)
EP (1) EP0005768B1 (xx)
JP (1) JPS54163809A (xx)
KR (1) KR830000527B1 (xx)
AT (2) AT365926B (xx)
AU (1) AU525695B2 (xx)
BE (1) BE876296A (xx)
CA (1) CA1141661A (xx)
CH (1) CH641044A5 (xx)
CS (1) CS214798B2 (xx)
DE (2) DE2966046D1 (xx)
DK (1) DK156004C (xx)
ES (1) ES480597A1 (xx)
FI (1) FI68359C (xx)
FR (1) FR2425856A1 (xx)
GR (1) GR68452B (xx)
HU (1) HU182746B (xx)
IL (1) IL57298A (xx)
IT (1) IT1116840B (xx)
LU (1) LU81272A1 (xx)
MC (1) MC1265A1 (xx)
NL (1) NL7903871A (xx)
NZ (1) NZ190462A (xx)
PH (1) PH15850A (xx)
PL (1) PL134004B1 (xx)
SE (1) SE450930B (xx)
SU (1) SU978715A3 (xx)
ZA (1) ZA787353B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3010002A1 (de) * 1980-03-15 1981-10-01 Hoechst Ag, 6000 Frankfurt Prostaglandine enthaltende pharmazeutische zubereitung
GB8814438D0 (en) * 1988-06-17 1988-07-20 Wellcome Found Compounds for use in medicine
DE68904358T2 (de) * 1988-06-17 1993-07-29 Wellcome Found Prostaglandinanaloge zur verwendung in der medizin.
JP3421330B2 (ja) * 2000-11-02 2003-06-30 持田製薬株式会社 ビダラビン注射用乾燥製剤
EP1238670A1 (en) * 2001-03-07 2002-09-11 Bruce Daniels Composition and method for treating and preventing cardiovascular disease and hypertension.
US7491263B2 (en) 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
DE602006005423D1 (de) * 2005-06-29 2009-04-16 Verisfield Uk Ltd Pharmazeutische Zusammensetzungen von Risperidon in wässriger Lösung
CA2641393C (en) 2006-02-03 2014-12-16 Scidose Llc Novel epoprostenol formulation and method of making thereof
CN103181893A (zh) * 2007-09-07 2013-07-03 联合治疗公司 针对革兰氏阴性细菌具有选择性杀菌活性的缓冲液及其使用方法
HU231031B1 (hu) 2016-03-23 2019-12-30 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Megnövelt stabilitású epoprostenol nátrium és eljárás előállítására
DE202024100435U1 (de) 2023-02-14 2024-02-22 Tomasz Dąbrowski Zaunfeld zum Aufbau einer Reitbande

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036954A (en) 1973-11-02 1977-07-19 Yamanouchi Pharmaceutical Co., Ltd. Stable prostaglandin E group-containing formulation
GB1504437A (en) 1974-03-08 1978-03-22 Dunlop Ltd Rubberplastics composites
DE2515001C2 (de) * 1975-04-04 1986-10-02 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandin enthaltende gefriergetrocknete Pulver
US3997587A (en) 1975-06-26 1976-12-14 Syntex (U.S.A.) Inc. D1- and 8R-9-fluoro-prostadienoic acid derivatives
US4005133A (en) 1975-10-14 1977-01-25 The Upjohn Company PGF2.sub.α, L-Arginine salt
FR2351112A1 (fr) * 1975-10-21 1977-12-09 Wellcome Found Derive de prostaglandine et medicament contenant ce derive
US4062964A (en) 1975-12-03 1977-12-13 Ciba-Geigy Corporation Antifertility-combinations
GB1583961A (en) * 1976-05-11 1981-02-04 Wellcome Found Prostacyclin and derivatives thereof
FR2390964A1 (fr) * 1977-05-20 1978-12-15 Wellcome Found Associations medicamenteuses comprenant de la prostacycline ou de la dihydroprostacycline

Also Published As

Publication number Publication date
IL57298A (en) 1983-09-30
FI68359C (fi) 1985-09-10
KR830000527B1 (ko) 1983-03-12
NZ190462A (en) 1982-05-31
EP0005768A1 (en) 1979-12-12
DE2966046D1 (en) 1983-09-15
GR68452B (xx) 1981-12-30
JPS6358810B2 (xx) 1988-11-17
SE450930B (sv) 1987-08-17
LU81272A1 (fr) 1979-12-07
IT7949064A0 (it) 1979-05-16
FR2425856A1 (fr) 1979-12-14
PL134004B1 (en) 1985-07-31
PL215627A1 (xx) 1981-08-07
PH15850A (en) 1983-04-13
CA1141661A (en) 1983-02-22
NL7903871A (nl) 1979-11-20
HU182746B (en) 1984-03-28
MC1265A1 (fr) 1980-03-28
ES480597A1 (es) 1980-08-16
CS214798B2 (en) 1982-05-28
IL57298A0 (en) 1979-09-30
DE2920020C2 (xx) 1988-09-01
DK201879A (da) 1979-11-18
FI791565A (fi) 1979-11-18
US4335139A (en) 1982-06-15
SU978715A3 (ru) 1982-11-30
EP0005768B1 (en) 1983-08-10
AU4704279A (en) 1979-11-22
JPS54163809A (en) 1979-12-26
AT365926B (de) 1982-02-25
CH641044A5 (de) 1984-02-15
ATE4411T1 (de) 1983-08-15
IT1116840B (it) 1986-02-10
FR2425856B1 (xx) 1982-06-25
DK156004B (da) 1989-06-12
FI68359B (fi) 1985-05-31
ZA787353B (en) 1980-08-27
AU525695B2 (en) 1982-11-25
SE7904284L (sv) 1979-11-18
ATA363479A (de) 1981-07-15
DE2920020A1 (de) 1979-11-29
DK156004C (da) 1989-11-06

Similar Documents

Publication Publication Date Title
SE8700498D0 (sv) Novel pharmaceologically active compounds
LU90366I2 (fr) Nasonex
FR2591485B1 (fr) Compositions stabilisees contenant l'activateur du plasminogene du tissu humain.
LU81272A1 (fr) Compositions pharmaceutiques contenant des prostaglandines
NZ192195A (en) 1-triazolyl-2-hydroxy-2-phenyl-3-aryl-propanes and pharmaceutical compositions
SE8704952L (sv) Farmaceutisk komposition
FI793261A (fi) Farmaceutisk komposition som innehaoller 3,4-dihydro-3-oxo-2-kinoxaliner
FR2666508B1 (fr) Compositions pharmaceutiques contenant des derives de furanne.
ES433860A1 (es) Procedimiento de preparacion de derivados del acido ciclo- pentano-carboxilico.
ES551886A0 (es) Procedimiento para la obtencion de s.s -dioxido de 3-acetilamino-4-metoxi-benzoisotiazol
ES2054089T3 (es) Formulaciones orales liquidas.
IT8620208A0 (it) Eteri del 7-ossabicicloeptano sostituiti quali analoghi di prostaglandine e relative composizioni farmaceutiche.
ATE22005T1 (de) Cremegrundlage.
GB2021581A (en) Stabilisation of PGl2 derivatives
SE8503447D0 (sv) Farmaceutiska och kosmetiska kompositioner, innehallande dihydroxi-1,8-fenyl-10-antron-9 som verksam bestandsdel, samt sett att framstella den verksamma foreningen
BE881799A (fr) Analogues de la protaglandine i2 et compositions pharmaceutiques les contenant
BE896870A (fr) Compositions pharmaceutiques contenant du salbutamol.

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: THE WELLCOME FOUNDATION LTD

Effective date: 19990516